Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOT vs Solifenacin for Urge Incontinence After Cesa/Vasa
NCT01737918Phase 2Unknown
- Sponsor
- University Hospital Cologne
- Start
- Jan 2013
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solifenacin in urge urinary incontinence (UUI), sponsored by University Hospital Cologne. Status: unknown.
02
Drugs
solifenacin
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT01737918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737918.